clinical loci currently offered by Signature Genomic Laboratories. Using a new proprietary approach, SignatureSelect puts the clinician in complete control of the loci they want analyzed for their patient, while still benefiting from a 5 day turn-around time. SignatureSelect is more comprehensive than single fluorescence in situ hybridization (FISH) assays and provides greater resolution than existing standard cytogenetic analysis.
Lisa G. Shaffer, Ph.D., Technical Laboratory Director, commented "Finally, a test that was created for the specific needs of the patient and the flexibility that the clinicians desire. SignatureSelect is a unique blend of high-tech with personal service. This is a very creative approach to providing the best possible care for our customers".
Bassem Bejjani, M.D. Medical Director noted "we developed SignatureSelect because many of our customers asked for it. Many clinicians wanted to control the number of loci to be tested. We felt that we should be responsive to their wishes. SignatureSelect adds another service to our menu and provides unique flexibility to the clinicians." Located in Spokane, WA, Signature Genomic Laboratories is the leader in cytogenetic analysis services using microarray based technologies. This revolutionary approach offers clinicians the opportunity to diagnose cytogenetic disorders in a fast, reliable, and comprehensive format and provide the best service possible for their patients.
Additional information on Signature Genomic Laboratories and its clinical cytogenetic services can be found on www.signaturegenomics. Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106; phone 215-521-8409; fax 215-521-8411; email alucches@lww.com. 
